PDF herunterladen
Thromb Haemost 1994; 72(01): 160-161
DOI: 10.1055/s-0038-1648830
Letter to the Editor
Schattauer GmbH Stuttgart

Potency and In Vivo Recovery of High Purity Factor VIII Concentrates

Authors

  • Marianne Mikaelsson

    1   Research and Development, University Hospital, Malmö, Sweden

  • Ulla Oswaldsson

    1   Research and Development, University Hospital, Malmö, Sweden

  • Inga Marie Nilsson

    2   Plasma Products, Kabi Pharmacia AB, and Department for Coagulation Disorders, University Hospital, Malmö, Sweden
Weitere Informationen

Publikationsverlauf

Received 24. Juni 1992

Accepted after revision 21. März 1994

Publikationsdatum:
12. Juli 2018 (online)

 als PDF herunterladen  Lizenzen und Reprints
Preview Container
 

  • References

  • 1 Barrowcliffe TW, Watton J, Harman A, Tubbs JE, Kemball-Cook G. Potency of high purity factor VIII concentrates. Lancet 1990; ii: 124
    PubMedSuche in Google Scholar
  • 2 Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131-137
    PubMedSuche in Google Scholar
  • 3 Nilsson IM, Bemtorp E. Clinical efficacy of clotting factor concentrates: survival, recovery and hemostatic capacity. In: Coagulation and Blood Transfusion Smit Sibinga CTh, Das PC, Mannucci PM. (eds) Dordrecht, The Netherlands: Kluwer Academic Publishers; 1991. pp 193-206
  • 4 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Thromb Haemost 1991; 66: 384-386
    Thieme ConnectPubMedSuche in Google Scholar